Skip to main content
    S

    SBC Medical Group Holdings Incorporated (SBC)

    Official site

    INDUSTRIALS • CONSULTING SERVICES • NASDAQ

    $6.18
    -1.17 (-15.92%)

    Market Cap: $755.92M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    SBC Medical Group Holdings Incorporated (SBC) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    SBC Medical Group Holdings (SBC) trades at 12.4x trailing earnings and 3.3x sales. Its forward P/E is 14.1x. The median P/E across 7 similar companies is 16.3x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 12.1% lower over the next year. Its free cash flow yield is 15.8%.

    MultipleValue
    P/E (trailing)12.4x
    Forward P/E14.1x
    Price to sales3.3x
    Price to book2.2x
    EV/EBITDA5.4x
    Price to FCF6.3x
    EV/FCF4.7x
    PEG2.8
    FCF yield15.8%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SBC

    What is SBC's forward P/E ratio?

    SBC Medical Group Holdings has a forward P/E ratio of 14.1x.

    Is SBC stock overvalued?

    GNG's valuation label for SBC is Fairly valued. Its P/E of 12.4x compares with a median of 16.3x across 7 similar companies.

    What is SBC's price to sales ratio?

    SBC Medical Group Holdings has a price to sales ratio of 3.3x.

    What is SBC's PEG ratio?

    SBC Medical Group Holdings has a PEG ratio of 2.8.